RecruitingNCT05442970
Cohort Study for Atrial Fibrillation Risk Stratification
An Epidemiologic, Prospective, Single Center Cohort Study for the Improvement of Atrial Fibrillation Risk Stratification in High Risk Individuals
Sponsor
Universitätsklinikum Hamburg-Eppendorf
Enrollment
3,000 participants
Start Date
Jun 1, 2013
Study Type
OBSERVATIONAL
Conditions
Summary
AFHRI is planned as a prospective, single-center cohort study in patients at high risk of AF.
Eligibility
Min Age: 18 YearsMax Age: 85 Years
Inclusion Criteria2
- Age 18 to 85 years;
- Personally signed informed consent
Exclusion Criteria2
- Insufficient knowledge of the German language, in order to understand study documents and computer assisted interview without translation;
- Physical or psychological incapability to cooperate in the investigations
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05442970
Related Trials
The CONFORM Pivotal Trial
NCT0514779283 locations
A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation
NCT0680821732 locations
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
NCT072275327 locations
A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
NCT0645509846 locations
The Fourth Left Atrial Appendage Occlusion Study
NCT05963698127 locations